Diagnosis of Fibroadenomas and Fibrocystic Changes

Diagnostic Approach

The National Comprehensive Cancer Network recommends ultrasound as the primary diagnostic tool for fibroadenomas and fibrocystic changes, while clinical examination alone is insufficient for definitive diagnosis 1, 2
For women younger than 30 years presenting with a palpable mass, initial diagnostic imaging should be breast ultrasound 3
Mammography is not recommended as the first imaging modality for women under 30 due to lower sensitivity in dense breast tissue common in younger women 3
Ultrasound can accurately characterize palpable solid masses as probably benign with risk of malignancy generally less than 2% 1

For women 30 years and older, diagnostic evaluation begins with both diagnostic mammography and ultrasound 1, 4
Ultrasound should be geographically correlated with the palpable mass in question 4
In some clinical circumstances with low suspicion, ultrasound alone may suffice for women 30-39 years of age 4

Fibroadenomas typically appear as solid masses with circumscribed margins, oval shape, and horizontal orientation 1, 2
Simple cysts are characterized as anechoic, well-circumscribed, round or oval with well-defined imperceptible wall and posterior enhancement 5, 3
Complicated cysts contain low-level echoes or intracystic debris without solid elements 5, 3
Complex cysts have both anechoic and echogenic components 5, 3

The American College of Radiology notes significant disagreement among experienced examiners may occur when evaluating breast masses 6
Clinical examination without imaging is insufficient for definitive diagnosis 1, 6
Cysts cannot reliably be distinguished from solid breast masses by palpation alone, with only 58% of palpable cysts correctly identified by physical examination 6

The National Comprehensive Cancer Network recommends women under 30 years should undergo ultrasound as the first imaging modality, while women 30 years and older should undergo both diagnostic mammography and ultrasound 1, 3, 4
BI-RADS 2 lesions are considered benign and require no further workup 7
BI-RADS 3 lesions are considered probably benign and require short-interval follow-up 7, 8
BI-RADS 4-5 lesions require tissue biopsy 1, 2

Imaging should precede biopsy in most situations due to potential alteration of imaging findings by the biopsy 1
BI-RADS imaging assessments must be correlated with clinical findings before final recommendations 1
There are clinical situations in which biopsy is warranted even with negative imaging results if clinical suspicion is high 1, 6